Thirunavukarasu, S., Jex, N., Chowdhary, A., Hassan, I. U., Straw, S., Craven, T. P., . . . Levelt, E. (2021). Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes.
Чикаго-гийн эшлэл (17 дахь хэвлэлт)Thirunavukarasu, Sharmaine, et al. Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes. 2021.
MLA -ийн эшлэл (9 дэх хэвлэлт)Thirunavukarasu, Sharmaine, et al. Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes. 2021.
Анхааруулга: Эдгээр ишлэлүүд үргэлж 100% үнэн зөв биш байж магадгүй.